Rockefeller Capital Management
NEO icon

Rockefeller Capital Management’s NeoGenomics NEO Stock Holding History

Rockefeller Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$990K Buy
53,925
+7,215
+15% +$119K ﹤0.01% 1753
2026
Q2 		$681K Sell
46,710
-2,569
-5% -$24.8K ﹤0.01% 1921
2026
Q1 		$366K Buy
49,279
+5,161
+12% +$54.3K ﹤0.01% 2151
2025
Q4 		$519K Buy
44,118
+597
+1% +$6.44K ﹤0.01% 1882
2025
Q3 		$336K Sell
43,521
-950
-2% -$6.65K ﹤0.01% 1962
2025
Q2 		$325K Sell
44,471
-6,164
-12% -$49.7K ﹤0.01% 1640
2025
Q1 		$481K Sell
50,635
-447
-0.9% -$5.58K ﹤0.01% 1488
2024
Q4 		$842K Buy
51,082
+16,831
+49% +$261K ﹤0.01% 1314
2024
Q3 		$505K Sell
34,251
-227
-0.7% -$3.55K ﹤0.01% 1424
2024
Q2 		$478K Buy
34,478
+128
+0.4% +$1.82K ﹤0.01% 1444
2024
Q1 		$540K Buy
34,350
+103
+0.3% +$1.59K ﹤0.01% 1453
2023
Q4 		$554K Buy
34,247
+12
+0% +$196 ﹤0.01% 1315
2023
Q3 		$421K Sell
34,235
-209
-0.6% -$3.11K ﹤0.01% 1339
2023
Q2 		$554K Sell
34,444
-499
-1% -$8.22K ﹤0.01% 1302
2023
Q1 		$607K Buy
34,943
+162
+0.5% +$2.31K ﹤0.01% 1263
2022
Q4 		$160K Buy
34,781
+386
+1% +$3.6K ﹤0.01% 1774
2022
Q3 		$145K Buy
34,395
+32,693
+1,921% +$325K ﹤0.01% 1797
2022
Q2 		$13K Buy
1,702
+1,217
+251% +$11.6K ﹤0.01% 2989
2022
Q1 		$5K Sell
485
-597
-55% -$12.6K ﹤0.01% 3342
2021
Q4 		$36K Buy
1,082
+436
+67% +$17.1K ﹤0.01% 2354
2021
Q3 		$31K Sell
646
-39
-6% -$1.8K ﹤0.01% 2381
2021
Q2 		$30K Buy
685
+178
+35% +$7.89K ﹤0.01% 2296
2021
Q1 		$24K Buy
507
+75
+17% +$3.9K ﹤0.01% 2204
2020
Q4 		$23K Buy
432
+391
+954% +$17.7K ﹤0.01% 1954
2020
Q3 		$1K Hold
41
– – ﹤0.01% 2509
2020
Q2 		$1K Hold
41
– – ﹤0.01% 2472
2020
Q1 		$1K Hold
41
– – ﹤0.01% 2294
2019
Q4 		$1K Buy
+41
New +$976 ﹤0.01% 1994

Other funds holding NEO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Rockefeller Capital Management's NEO Position: Q3 2026 in Review

Rockefeller Capital Management increased its NeoGenomics (NEO) stake by 15% in Q3 2026, buying an estimated $119K and bringing the position to 53,925 shares worth $990K. The position accounts for ﹤0.01% of the portfolio, ranked #1753.

Rockefeller Capital Management first reported a position in NEO in Q4 2019 and has held it in 28 quarters since. 231 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Rockefeller Capital Management held 53,925 shares of NeoGenomics worth $990K as of Q3 2026.
  • Rockefeller Capital Management bought 7,215 NeoGenomics shares in Q3 2026, an estimated $119K.
  • NeoGenomics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #1753 holding.
  • Rockefeller Capital Management first reported a position in NeoGenomics in Q4 2019 and has held it in 28 quarters since.
  • 231 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.